| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $75.4B | $62.1B | $49.6B | $47.7B | $42.7B | $39.0B | $32.0B | $26.8B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $8.5B | $3.9B | $0.7B | $3.4B | $5.7B | $4.0B | $2.6B | $1.6B |
| EPS (Basic) | $14.45 | $6.61 | $1.19 | $5.69 | $9.71 | $6.75 | $4.45 | $2.74 |
| EPS (Diluted) | $14.40 | $6.58 | $1.18 | $5.66 | $9.66 | $6.72 | $4.42 | $2.72 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $105.7B | $88.7B | $75.5B | $71.1B | $64.1B | $54.9B | $46.6B | $38.7B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.1B | $0.1B | $0.2B | $0.2B | $0.1B | $0.2B | $0.1B | $0.3B |
| Total Liabilities | $80.2B | $68.4B | $59.6B | $52.9B | $47.1B | $41.0B | $35.5B | $28.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $25.6B | $20.3B | $15.9B | $18.2B | $17.0B | $13.7B | $10.8B | $9.3B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $15.1B | $10.6B | $6.8B | $7.8B | $6.9B | $6.3B | $6.3B | $3.8B |
| Investing Cash Flow | $-13.7B | $-10.8B | $-8.0B | $-3.1B | $-6.1B | $-4.3B | $-7.3B | $-3.4B |
| Capital Expenditures | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B | $0.4B | $0.3B | $0.2B |
| Financing Cash Flow | $-1.3B | $0.1B | $1.1B | $-4.5B | $-0.9B | $-1.8B | $0.8B | $-0.3B |